Bionano genomics announces participation at the european society of human genetics conference (eshg) 2022 featuring ogm across a broad range of clinical research applications and a collaborative product development with hamilton

San diego, june 10, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced its participation at the european society of human genetics (eshg) 2022 conference, with 13 scientific and poster presentations highlighting the application of ogm across rare undiagnosed genetic disease and genetic disorders. additionally, bionano and hamilton will present the long string vantage, the world's first automation solution for uhmw extraction used in ogm.
BNGO Ratings Summary
BNGO Quant Ranking